Clinical Trial Information
LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early-Stage Breast Cancer
- Protocol Number: A012301
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Phase: III
- NCT ID: NCT06671912
Scope Information
- Scope:
- National
- Disease Site(s):
- Breast
